{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:16:06Z","timestamp":1777616166804,"version":"3.51.4"},"reference-count":21,"publisher":"Royal College of General Practitioners","issue":"676","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent guidelines recommend genetic counselling and DNA testing (GCT) for patients with ovarian cancer and survivors of ovarian cancer. Finding survivors of ovarian cancer is challenging. Detecting and referring them for GCT via primary care, to allow proper screening recommendations for patients and their family, may be a solution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare the effectiveness and acceptance of two pilot strategies directed at case finding women with a history of ovarian cancer for referral for GCT by their GP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>Non-randomised comparison of the pilot implementation of two case-finding strategies for women with a history of ovarian cancer in Dutch primary care from May 2016 to April 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Strategy A (unsupported) asked GPs to identify and refer eligible patients with a history of ovarian cancer. Strategy B (ICT-supported) provided GPs with information and communication technology (ICT) support to identify patients with a history of ovarian cancer electronically. The effectiveness of each strategy was assessed as the proportion of patients who were approached, referred for GCT, and seen by the clinical geneticist. Acceptance of each strategy was assessed by the intervention uptake of GP practices and GP and patient questionnaires.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen out of 30 (63%) patients identified with a history of ovarian cancer were deemed eligible for referral for strategy A, and 39 out of 94 (41%) for strategy B. For each strategy, eight patients were referred and five (63%) were seen for GCT. The intervention uptake by GP practices was 31% (11 out of 36) for strategy A and 46% (21 out of 46) for strategy B. GPs considered \u2018relevance\u2019 and \u2018workability\u2019 as facilitators across both strategies whereas, for strategy B, technical barriers hindered implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The effectiveness and acceptance of both strategies for case finding of survivors of ovarian cancer in primary care for GCT is promising, but larger studies are required before wide-scale implementation is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp18x699533","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:26:22Z","timestamp":1540250782000},"page":"e750-e756","source":"Crossref","is-referenced-by-count":4,"title":["Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care"],"prefix":"10.3399","volume":"68","author":[{"given":"Charles W","family":"Helsper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth M","family":"Van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E","family":"Velthuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niek J","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy PH","family":"Beijaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Butter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen PL","family":"van Gent-Wagemakers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els O","family":"Witteveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M","family":"van Dulmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet GEM","family":"Ausems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"2020081209323814000_68.676.e750.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"2020081209323814000_68.676.e750.2","unstructured":"The Netherlands Cancer Registry. Cancer figures, (In Dutch). Dutch Cancer Registry. https:\/\/www.cijfersoverkanker.nl\/selecties\/Dataset_1\/img5bab9248cc12d (accessed 2 Oct 2018)."},{"key":"2020081209323814000_68.676.e750.3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejca.2016.03.009","article-title":"Germline BRCA1\/2 mutation testing is indicated in every patient with epithelial ovarian cancer: a systematic review","volume":"61","author":"Arts-de Jong","year":"2016","journal-title":"Eur J Cancer"},{"issue":"21","key":"2020081209323814000_68.676.e750.4","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020081209323814000_68.676.e750.5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2020081209323814000_68.676.e750.6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"2020081209323814000_68.676.e750.7","unstructured":"Comprehensive Cancer Centre the Netherlands (IKNL). (2015) National guideline: hereditary and familial ovarian carcinoma. [In Dutch]. http:\/\/www.oncoline.nl\/erfelijk-en-familiair-ovariumcarcinoom (accessed 2 Oct 2018)."},{"issue":"23","key":"2020081209323814000_68.676.e750.8","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"2020081209323814000_68.676.e750.9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12325-016-0281-1","article-title":"Selecting patients with ovarian cancer for germline BRCA mutation testing: findings from guidelines and a systematic literature review","volume":"33","author":"Eccles","year":"2016","journal-title":"Adv Ther"},{"issue":"20","key":"2020081209323814000_68.676.e750.10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1200\/JCO.2016.70.3439","article-title":"Traceback: a proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach","volume":"35","author":"Samimi","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020081209323814000_68.676.e750.11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2020081209323814000_68.676.e750.12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fonc.2016.00119","article-title":"Ovarian cancer and BRCA1\/2 testing: opportunities to improve clinical care and disease prevention","volume":"6","author":"Karakasis","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"2020081209323814000_68.676.e750.13","first-page":"160","article-title":"Educational needs in genetic medicine: primary care perspectives","volume":"11","author":"Trinidad","year":"2008","journal-title":"Community Genet"},{"issue":"5","key":"2020081209323814000_68.676.e750.14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/fampra\/cmn053","article-title":"Interviews with primary care physicians regarding taking and interpreting the cancer family history","volume":"25","author":"Wood","year":"2008","journal-title":"Fam Pract"},{"issue":"1","key":"2020081209323814000_68.676.e750.15","first-page":"45","article-title":"Genetic susceptibility to cancer. Family physicians\u2019 experience","volume":"49","author":"Carroll","year":"2003","journal-title":"Can Fam Physician"},{"issue":"2","key":"2020081209323814000_68.676.e750.16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12687-013-0161-1","article-title":"Patient-reported hereditary breast and ovarian cancer in a primary care practice","volume":"5","author":"Quillin","year":"2014","journal-title":"J Community Genet"},{"issue":"9","key":"2020081209323814000_68.676.e750.17","doi-asserted-by":"crossref","first-page":"e012669","DOI":"10.1136\/bmjopen-2016-012669","article-title":"Do GPs know their patients with cancer? Assessing the quality of cancer registration in Dutch primary care: a cross-sectional validation study","volume":"6","author":"Sollie","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"2020081209323814000_68.676.e750.18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12687-012-0090-4","article-title":"Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral","volume":"3","author":"van Riel","year":"2012","journal-title":"J Community Genet"},{"issue":"9","key":"2020081209323814000_68.676.e750.19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.gim.0000182895.28432.c7","article-title":"Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem","volume":"7","author":"Baars","year":"2005","journal-title":"Genet Med"},{"issue":"1","key":"2020081209323814000_68.676.e750.20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7861\/clinmedicine.9-1-49","article-title":"The development of core learning outcomes relevant to clinical practice: identifying priority areas for genetics education for non-genetics specialist registrars","volume":"9","author":"Burke","year":"2009","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"2020081209323814000_68.676.e750.21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jval.2017.01.004","article-title":"A cost-effectiveness evaluation of germline BRCA1 and BRCA2 testing in UK women with ovarian cancer","volume":"20","author":"Eccleston","year":"2017","journal-title":"Value Health"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgp18X699533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T19:50:02Z","timestamp":1645818602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjgp.org\/lookup\/doi\/10.3399\/bjgp18X699533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":21,"journal-issue":{"issue":"676","published-online":{"date-parts":[[2018,10,25]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.3399\/bjgp18X699533"],"URL":"https:\/\/doi.org\/10.3399\/bjgp18x699533","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]}}}